Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Marja T. Nevalainen, Peter S. LaViolette et al.|Cancers|2021Cited by 24
Stat5 induces androgen receptor ( <i>AR</i> ) gene transcription in prostate cancer and offers a druggable pathway to target AR signalingCristina Maranto, Marja T. Nevalainen, Lavannya Sabharwal et al.|Science Advances|2024Cited by 10